Shire/Noven's Daytrana Receives FDA Wake-up Call: Side Effects Greater Than Concerta, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will ask FDA's Psychopharmacologic Drugs Advisory Committee whether the methylphenidate patch is "acceptably safe" for approval at Dec. 2 meeting.